Outcomes in ovarian cancer among hispanic women living in the United States: A population-based analysis

Pathology Research International

Volumn 2013, Issue , 2013, Pages

  Ibeanu, Okechukwu A ^a   Díaz Montes, Teresa P ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904363770     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2013/672710     Document Type: Article

References (15)

1. Nasca P. C., Pastides H., Fundamentals of Cancer Epidemiology 2008 2nd Sudbury, Mass, USA Jones and Bartlett
2. Siegel R., Naishadham D., Jemal A., Cancer Statistics 2012. CA-A Cancer Journal for Clinicians 2012 62 10 29
3. Cancer Statistics. American Cancer Society, 2008
4. Badgwell D., Bast R. C., Early detection of ovarian cancer. Disease Markers 2007 23 5-6 397 410 2-s2.0-36448975871
5. Ries L., Melbert D., Krapcho M., SEER Cancer Statistics Review, 1975. National Cancer Institute, Bethesda, Md, USA, 2005, http://seer.cancer.gov/csr/ 1975-2005/
6. United States Cancer Statistics: 1999-2005 Incidence and Mortality Web-based Report. Atlanta. U.S. Department of Health and Human Services, Centers of Disease Control and Prevention and National Cancer Institute, 2009, http://www.cdc.gov/uscs
7. De Alba I., Sweningson J. M., English proficiency and physicians' recommendation of Pap smears among Hispanics. Cancer Detection and Prevention 2006 30 3 292 296 2-s2.0-33746742935 10.1016/j.cdp.2006.05.003
8. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Incidence-SEER 12 Regs Public-Use. November 2007 Sub (1973-2005). National Cancer Institute, 2008, http://www.seer.cancer.gov/
9. Fritz A., Percy C., Jack A., International Classification of Diseases for Oncology 2000 3rd Geneva, Switzerland World Health Organization
10. Derose K. P., Escarce J. J., Lurie N., Immigrants and health care: sources of vulnerability. Health Affairs 2007 26 5 1258 1268 2-s2.0-35148882475 10.1377/hlthaff.26.5.1258
11. Schiff M., Becker T. M., Smith H. O., Gilliland F. D., Key C. R., Ovarian cancer incidence and mortality in American Indian, Hispanic, and non-Hispanic white women in New Mexico. Cancer Epidemiology Biomarkers and Prevention 1996 5 5 323 327 2-s2.0-0029874035
12. Weitzel J. N., Lagos V., Blazer K. R., Nelson R., Ricker C., Herzog J., McGuire C., Neuhausen S., Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiology Biomarkers and Prevention 2005 14 7 1666 1671 2-s2.0-22244470367 10.1158/1055-9965.EPI-05-0072
13. Torres D., Rashid M. U., Gil F., Umana A., Ramelli G., Robledo J. F., Tawil M., Torregrosa L., Briceno I., Hamann U., High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. Breast Cancer Research and Treatment 2007 103 2 225 232 2-s2.0-34249040579 10.1007/s10549-006-9370-1
14. Eisenkop S. M., Spirtos N. M., Lin W. C. M., »Optimal» cytoreduction for advanced epithelial ovarian cancer: a commentary. Gynecologic Oncology 2006 103 1 329 335 2-s2.0-33748683621 10.1016/j.ygyno.2006.07.004
15. Chan J. K., Zhang M., Hu J. M., Shin J. Y., Osann K., Kapp D. S., Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. Journal of Surgical Oncology 2008 97 2 103 107 2-s2.0-38649105490 10.1002/jso.20932